Pharmaceutical giant MSD, which is part of the US group Merck, is planning to build a new €140m manufacturing facility linked to an existing plant in Ballydine, Co Tipperary. “In order to resolve this manufacturing capability deficiency, MSD Ireland has initiated a project to build a small-scale, single-train facility at Ballydine,” MSD said in the document. The proposed facility is referred to as a “pilot plant”, which is for the manufacture of active pharmaceutical ingredients (APIs). According to the plans, the new pharmaceutical pilot manufacturing facility would be approximately 3,266sqm in size and around 20.75m high. MSD’s facility at Ballydine is a 33-hectare bulk pharmaceutical manufacturing facility located approximately 12km east of the town of Clonmel.

Source: Irish Independent May 09, 2021 03:09 UTC